{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:41:08Z","timestamp":1790260868701,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.ijantimicag.2009.04.007","type":"journal-article","created":{"date-parts":[[2009,7,22]],"date-time":"2009-07-22T05:19:43Z","timestamp":1248239983000},"page":"246-251","source":"Crossref","is-referenced-by-count":12,"title":["Carbapenems and subsequent multiresistant bloodstream infection: does treatment duration matter?"],"prefix":"10.1016","volume":"34","author":[{"given":"Annabelle D.","family":"Donaldson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Razak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Jia","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale A.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Tambyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2009.04.007_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0002-9343(80)90102-3","article-title":"Gram-negative bacteremia IV. Re-evaluation of clinical features and treatment in 612 patients","volume":"68","author":"Kruger","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1378\/chest.115.2.462","article-title":"Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients","volume":"115","author":"Kollef","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1378\/chest.111.3.676","article-title":"Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia","volume":"111","author":"Luna","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1378\/chest.122.1.262","article-title":"Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia","volume":"122","author":"Iregui","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.118.1.146","article-title":"The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting","volume":"118","author":"Ibrahim","year":"2000","journal-title":"Chest"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2009.04.007_bib6","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1086\/499405","article-title":"Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms","volume":"42","author":"Niederman","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib7","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1378\/chest.122.6.2183","article-title":"Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU","volume":"122","author":"H\u00f6ffken","year":"2002","journal-title":"Chest"},{"issue":"Suppl. B","key":"10.1016\/j.ijantimicag.2009.04.007_bib8","first-page":"19","article-title":"Clinical and molecular epidemiology of invasive Klebsiella pneumoniae infections in the extended-spectrum \u03b2-lactamase (ESBL) era","volume":"56","author":"Tambyah","year":"2001","journal-title":"Med J Malaysia"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/338639","article-title":"Nosocomial antibiotic resistance in multiple Gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites","volume":"34","author":"Rahal","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib10","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1128\/AAC.43.6.1379","article-title":"Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents","volume":"43","author":"Carmeli","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib11","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1128\/AAC.46.9.2920-2925.2002","article-title":"Consumption of imipenem correlates with \u03b2-lactam resistance in Pseudomonas aeruginosa","volume":"46","author":"Lepper","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1128\/AAC.48.1.224-228.2004","article-title":"Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study","volume":"48","author":"Lee","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib13","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1469-0691.2005.01184.x","article-title":"Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection","volume":"11","author":"del Mar Thomas","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1754-4505.2006.tb01440.x","article-title":"Reduction in incidence of methicillin-resistant Staphylococcus aureus (MRSA) after radical surgery for head and neck cancer","volume":"26","author":"Morimoto","year":"2006","journal-title":"Spec Care Dentist"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijantimicag.2005.04.007","article-title":"Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents","volume":"26","author":"Hsueh","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib16","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Fifteenth informational supplement. Document M100-S15. Wayne, PA: CLSI; 2005."},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib17","series-title":"Clinical practice guidelines. Use of antibiotics in adults","author":"Ministry of Health, Singapore","year":"2006"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1086\/520193","article-title":"Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2 Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals","volume":"29","author":"Fridkin","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib19","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. The ATC\/DDD system. http:\/\/www.whocc.no\/atcddd [accessed 30.11.08]."},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib20","doi-asserted-by":"crossref","first-page":"834","DOI":"10.7326\/0003-4819-136-11-200206040-00013","article-title":"The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, Gram-negative bacilli, Clostridium difficile, and Candida","volume":"136","author":"Safdar","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib21","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/00003246-199906000-00026","article-title":"Colonization with broad-spectrum cephalosporin-resistant Gram-negative bacilli in intensive care units during a nonoutbreak period: prevalence, risk factors, and rate of infection","volume":"27","author":"D\u2019Agata","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.279.5.365","article-title":"Low dosage and long treatment duration of \u03b2-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae","volume":"279","author":"Guillemot","year":"1998","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib23","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1086\/374556","article-title":"Streptococcus pneumoniae bacteremia: duration of previous antibiotic use and association with penicillin resistance","volume":"36","author":"Ruhe","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1164\/ajrccm.162.2.9909095","article-title":"Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: A proposed solution for indiscriminate antibiotic prescription","volume":"162","author":"Singh","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib25","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","article-title":"Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults","volume":"290","author":"Chastre","year":"2003","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/01.CCM.0000152230.53473.A1","article-title":"First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit","volume":"33","author":"Nseir","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3201\/eid1202.050145","article-title":"A systematic review of antimicrobial drug prescribing in hospitals","volume":"12","author":"Davey","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s100960050324","article-title":"A Dutch approach to methicillin-resistant Staphylococcus aureus","volume":"18","author":"Verhoef","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib29","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/01.CCM.0000163223.26234.56","article-title":"How many infections are caused by patient-to-patient transmission in intensive care units?","volume":"33","author":"Grundmann","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib30","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/clinids\/18.6.929","article-title":"Assessment of bacterial cross-transmission as a cause of infections in patients in intensive care units","volume":"18","author":"Chetchotisakd","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1086\/502021","article-title":"How many nosocomial infections are associated with cross-transmission? A prospective cohort study in a surgical intensive care unit","volume":"23","author":"Weist","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0750-7658(03)00136-9","article-title":"Pseudomonas aeruginosa epidemiology in intensive care units: importance of cross-transmission","volume":"22","author":"Bertrand","year":"2003","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib33","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1128\/AAC.00466-06","article-title":"Impact of inactive empiric antimicrobial therapy on inpatient mortality and length of stay","volume":"50","author":"Scarsi","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib34","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/00365540310015953","article-title":"Impact of antibiotic resistance on the treatment of sepsis","volume":"35","author":"Turnidge","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib35","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1469-0691.2003.00656.x","article-title":"The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit","volume":"9","author":"Zaragoza","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib36","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/jac\/dkl006","article-title":"Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on outcome","volume":"57","author":"Fang","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib37","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1086\/377534","article-title":"International Pneumococcal Study Group. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome","volume":"37","author":"Yu","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.04.007_bib38","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"American Thoracic Society; Infectious Diseases Society of America","year":"2005","journal-title":"Am J Respir Crit Care Med"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909001964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909001964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T12:26:11Z","timestamp":1558441571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857909001964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0924857909001964"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2009.04.007","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}